Key Details
Annual ROE
-110.15%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Aug 22, 2022Recent annual earnings:
Mar 30, 2022Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Nov 02, 2022Analyst ratings
Recent major analysts updates
03 Feb '23 HC Wainwright & Co.
Neutral17 May '22 HC Wainwright & Co.
Buy08 Mar '22 HC Wainwright & Co.
Buy06 Oct '21 HC Wainwright & Co.
BuyScreeners with VYNT included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Vyant Bio doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
Vyant Bio to pursue listing on OTC Pink Open Market
VYNT
Proactive Investors12 May 2023
Vyant Bio (NASDAQ:VYNT) said its last day of trading on the Nasdaq Capital Market will be May 12, 2023. following its filing to voluntarily delist from the exchange.
Why Is Vyant Bio (VYNT) Stock Down 35% Today?
VYNT
InvestorPlace25 April 2023
Vyant Bio (NASDAQ: VYNT ) stock is taking a beating on Tuesday after the biotechnology company announced plans to delist its shares. According to a press release, the company's Board of Directors determined that a voluntary delisting of shares was in order.
FAQ
- What is the primary business of Vyant Bio?
- What is the ticker symbol for Vyant Bio?
- Does Vyant Bio pay dividends?
- What sector is Vyant Bio in?
- What industry is Vyant Bio in?
- What country is Vyant Bio based in?
- When did Vyant Bio go public?
- Is Vyant Bio in the S&P 500?
- Is Vyant Bio in the NASDAQ 100?
- Is Vyant Bio in the Dow Jones?
- When was Vyant Bio's last earnings report?
- When does Vyant Bio report earnings?
- Should I buy Vyant Bio stock now?
What is the primary business of Vyant Bio?
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). The company is based in Cherry Hill, New Jersey.
What is the ticker symbol for Vyant Bio?
The ticker symbol for Vyant Bio is NASDAQ:VYNT
Does Vyant Bio pay dividends?
No, Vyant Bio does not pay dividends
What sector is Vyant Bio in?
Vyant Bio is in the Healthcare sector
What industry is Vyant Bio in?
Vyant Bio is in the Biotechnology industry
What country is Vyant Bio based in?
Vyant Bio is headquartered in United States
When did Vyant Bio go public?
Vyant Bio's initial public offering (IPO) was on 01 April 2021
Is Vyant Bio in the S&P 500?
No, Vyant Bio is not included in the S&P 500 index
Is Vyant Bio in the NASDAQ 100?
No, Vyant Bio is not included in the NASDAQ 100 index
Is Vyant Bio in the Dow Jones?
No, Vyant Bio is not included in the Dow Jones index
When was Vyant Bio's last earnings report?
Vyant Bio's most recent earnings report was on 22 August 2022
When does Vyant Bio report earnings?
The date for Vyant Bio's next earnings report has not been announced yet
Should I buy Vyant Bio stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions